Mindset Pharma Inc.
MSSTF · OTC
6/30/2022 | 6/30/2021 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Revenue | $3,906 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $3,906 | $0 | $0 | $0 |
| % Margin | 100% | – | – | – |
| R&D Expenses | $7,394 | $2,222 | $0 | $0 |
| G&A Expenses | $13,088 | $6,242 | $46 | $14 |
| SG&A Expenses | $13,088 | $6,242 | $46 | $14 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$33 | -$71 | $0 | $0 |
| Operating Expenses | $20,482 | $8,464 | $46 | $14 |
| Operating Income | -$16,577 | -$5,346 | -$58 | -$14 |
| % Margin | -424.4% | – | – | – |
| Other Income/Exp. Net | -$33 | -$6,308 | $25 | $0 |
| Pre-Tax Income | -$16,610 | -$11,653 | -$33 | -$14 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$16,610 | -$11,653 | -$33 | -$14 |
| % Margin | -425.2% | – | – | – |
| EPS | -0.18 | -0.2 | -0.001 | -0 |
| % Growth | 10% | -39,900% | -150% | – |
| EPS Diluted | -0.18 | -0.2 | -0.001 | -0 |
| Weighted Avg Shares Out | 90,061 | 57,659 | 66,141 | 66,141 |
| Weighted Avg Shares Out Dil | 90,061 | 57,659 | 66,141 | 66,141 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $45 | $22 | $172 | $161 |
| EBITDA | -$16,532 | -$5,323 | -$58 | -$14 |
| % Margin | -423.2% | – | – | – |